Respiratory diseases like COVID-19 may leave lasting cardiovascular mark

  • Xiong TY & al.
  • Eur Heart J
  • 18 mar. 2020

  • de Emily Willingham, PhD
  • Clinical Essentials
El acceso al contenido completo es sólo para profesionales sanitarios registrados. El acceso al contenido completo es sólo para profesionales sanitarios registrados.

Takeaway

  • Cardiologists should be alert to potential lasting cardiovascular effects of viruses such as SARS-CoV-2, which causes COVID-19, says the European Society of Cardiology.
  • Survivors of the previous SARS outbreak had dyslipidemic effects for years, and pneumonia survivors can also experience a lingering influence on cardiovascular disease (CVD).

Why this matters

  • As clinicians grapple with CVD as a risk factor with COVID-19, they also need to be alert to CVD-related sequelae in survivors.
  • Chronic CVD complications are common with pneumonia, say these authors.

Key comments

  • Influenza is well known for exacerbating heart failure and for its association with cardiac complications, such as myocardial infarction.
  • Previous coronavirus outbreaks (SARS, MERS) have also been linked to significant cardiovascular comorbidities and complications, the authors say, including arrhythmias and sudden cardiac death.
  • Myocarditis and decreased ejection fraction have also been identified.
  • In the current outbreak, CVD is a known risk factor.
  • Clinicians should attend to coagulation status of patients who have stents and track platelet function.
  • Multiorgan failure with cardiac involvement has been seen with COVID-19.
  • For survivors, cardiovascular effects can persist, and clinicians should be alert to a history of COVID-19 or other SARS disease.
  • More research is badly needed, the authors write.